Scinai Immunotherapeutics (SCNI) Earnings Date
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
No quarter above is scored yet. 2 reported before we stored a consensus for them, so they are not scored. We never backfill an estimate we didn't observe.
| Report | Act EPS | Act rev | Reaction |
|---|---|---|---|
| May 15, 2023 filed | −0.00b | $0.00 | —filing date only |
| May 5, 2022 E | −0.00b | $0.00 | —estimated date |
E marks a report date we estimated from the fiscal period end, because we found no results release and no usable filing date for that quarter. Those rows show no reaction: a move measured from a day we guessed is not a reaction to the release, and we would rather leave it blank than publish it.
b Basic EPS. The company's diluted figure is not in our data feed for this period; its reported basic EPS agrees with net income to common shareholders over basic shares within 2%, so it is shown instead.
filed marks a quarter where we found no results release and hold only the date its report was filed. A filing can trail the release by days or weeks, so those rows show no reaction rather than the move of an unrelated session.
| Measure | Dec '26 | Mar '27 |
|---|---|---|
| No. of analysts | 1 | 1 |
| Avg estimate | −8.50 | −85.00 |
| Low estimate | −8.50 | −85.00 |
| High estimate | −8.50 | −85.00 |
| Year-ago EPS | — | — |
| Implied growth | — | — |
| Measure | Dec '26 | Mar '27 |
|---|---|---|
| No. of analysts | 1 | 1 |
| Avg estimate | $2.0M | $2.1M |
| Low estimate | $2.0M | $2.1M |
| High estimate | $2.0M | $2.1M |
| Year-ago revenue | — | — |
| Implied growth | — | — |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 |
|---|---|---|
| Current estimate | −8.50 | −85.00 |
| 7 days ago | −8.50 | — |
| 30 days ago | −8.50 | — |
| 60 days ago | −8.50 | — |
| 90 days ago | −8.50 | — |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus has held at −$8.50 across 90 tracked days since Jul 10, 2026. A bar that has not moved is an answer, not a gap: a beat against a flat bar is a real beat. Per-analyst up/down revision counts aren't in our data feed.

